EVRG vs MXCT · P/E 22, rev $5.85B vs rev $38.6M
Evergy, Inc. (EVRG) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Latest reported EVRG revenue for 2024-12-31 was $5.85B. Net income was $885.8M. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
EVRG currently screens at market cap $19.10B and trailing P/E 22.0. MXCT currently screens at market cap $124.3M.
Not investment advice. Open the EVRG and MXCT stock pages for the full models.
Not investment advice.